Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001075269 | SCV001240884 | likely pathogenic | Retinal dystrophy | 2017-09-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002554754 | SCV003000124 | pathogenic | not provided | 2025-01-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser243Lysfs*80) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is present in population databases (no rsID available, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 866898). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV003455411 | SCV004182954 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003455411 | SCV004200702 | likely pathogenic | Retinitis pigmentosa 39 | 2024-03-05 | criteria provided, single submitter | clinical testing |